标题
No central action of CGRP antagonising drugs in the GTN mouse model of migraine
作者
关键词
-
出版物
CEPHALALGIA
Volume -, Issue -, Pages 033310242091491
出版商
SAGE Publications
发表日期
2020-03-30
DOI
10.1177/0333102420914913
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
- (2019) David W Dodick CEPHALALGIA
- Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase Activating Peptide
- (2019) Cristina Moldovan Loomis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats
- (2019) Kirk W Johnson et al. CEPHALALGIA
- Calcitonin Gene‐Related Peptide Modulators – The History and Renaissance of a New Migraine Drug Class
- (2019) Richard Hargreaves et al. HEADACHE
- Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain
- (2019) Sarah L Christensen et al. CEPHALALGIA
- Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
- (2019) Michel D Ferrari et al. LANCET
- TRPA1/NOX in the soma of trigeminal ganglion neurons mediates migraine-related pain of glyceryl trinitrate in mice
- (2018) Ilaria Maddalena Marone et al. BRAIN
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- Targeted Nitric Oxide Synthase Inhibitors for Migraine
- (2018) Amynah A. Pradhan et al. Neurotherapeutics
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers
- (2018) Cristina Parrado-Fernández et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Vascular Contributions to Migraine: Time to Revisit?
- (2018) Bianca N. Mason et al. Frontiers in Cellular Neuroscience
- Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity
- (2018) Simon Akerman et al. BRAIN
- The Emperor’s New Gepants: Are the Effects of the New Oral CGRP Antagonists Clinically Meaningful?
- (2018) Peer Tfelt-Hansen et al. HEADACHE
- Changes in Brainstem Pain Modulation Circuitry Function over the Migraine Cycle
- (2018) Kasia K. Marciszewski et al. JOURNAL OF NEUROSCIENCE
- Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
- (2018) Uwe Reuter et al. LANCET
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Delta opioid receptor agonists are effective for multiple types of headache disorders
- (2018) Laura S. Moye et al. NEUROPHARMACOLOGY
- Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery
- (2017) Michelle E. Pizzo et al. JOURNAL OF PHYSIOLOGY-LONDON
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Human models of migraine — short-term pain for long-term gain
- (2017) Messoud Ashina et al. Nature Reviews Neurology
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine
- (2017) Smriti Iyengar et al. PAIN
- Pathophysiology of Migraine: A Disorder of Sensory Processing
- (2017) Peter J. Goadsby et al. PHYSIOLOGICAL REVIEWS
- The effects of acute and preventive migraine therapies in a mouse model of chronic migraine
- (2016) Alycia F Tipton et al. CEPHALALGIA
- Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat
- (2016) L.F. Ferrari et al. NEUROSCIENCE
- H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO–TRPA1–CGRP signalling pathway
- (2015) Mirjam Eberhardt et al. Nature Communications
- Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists
- (2014) Pramod Joshi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience
- (2013) Messoud Ashina et al. CEPHALALGIA
- Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment
- (2013) Kristin Seiler et al. JOURNAL OF HEADACHE AND PAIN
- Physiology of Blood–Brain Interfaces in Relation to Brain Disposition of Small Compounds and Macromolecules
- (2013) N. Strazielle et al. MOLECULAR PHARMACEUTICS
- CGRP and migraine: Could PACAP play a role too?
- (2013) Eric A. Kaiser et al. NEUROPEPTIDES
- Characterization of a novel model of chronic migraine
- (2013) Amynah A. Pradhan et al. PAIN
- Pathophysiology of migraine
- (2012) PeterJ Goadsby Annals of Indian Academy of Neurology
- Towards a reliable animal model of migraine
- (2012) Jes Olesen et al. CEPHALALGIA
- Investigation of the Role of FcγR and FcRn in mAb Distribution to the Brain
- (2012) Lubna Abuqayyas et al. MOLECULAR PHARMACEUTICS
- Possible site of action of CGRP antagonists in migraine
- (2011) Peer Tfelt-Hansen et al. CEPHALALGIA
- CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine
- (2010) JF Tvedskov et al. CEPHALALGIA
- Oral nitric-oxide donor glyceryl-trinitrate induces sensitization in spinal cord pain processing in migraineurs: A double-blind, placebo-controlled, cross-over study
- (2010) Armando Perrottal et al. EUROPEAN JOURNAL OF PAIN
- Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist
- (2010) C. A. Salvatore et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers
- (2010) M. S. Asghar et al. NEUROLOGY
- Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus
- (2009) Marie-Luise Sixt et al. BRAIN
- Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice
- (2009) EA Bates et al. CEPHALALGIA
- Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment
- (2009) Peer C. Tfelt-Hansen JOURNAL OF HEADACHE AND PAIN
- Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
- (2009) A. Recober et al. JOURNAL OF NEUROSCIENCE
- Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients
- (2008) L. H. Lassen et al. JOURNAL OF HEADACHE AND PAIN
- Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery
- (2007) L Edvinsson et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started